Myomo (MYO) Net Margin Growth (1y) (2017 - 2025)
Myomo (MYO) Net Margin Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 67.00 |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,580.00 |
| Jun 30, 2025 | -3,308.00 |
| Mar 31, 2025 | 6,692.00 |
| Dec 31, 2024 | 5,647.00 |
| Sep 30, 2024 | 2,945.00 |
| Jun 30, 2024 | 211.00 |
| Mar 31, 2024 | -2,544.00 |
| Dec 31, 2023 | -887.00 |
| Sep 30, 2023 | 3,136.00 |
| Jun 30, 2023 | 6,208.00 |
| Mar 31, 2023 | -394.00 |
| Dec 31, 2022 | 2,557.00 |
| Sep 30, 2022 | -2,439.00 |
| Jun 30, 2022 | 534.00 |
| Mar 31, 2022 | 5,394.00 |
| Dec 31, 2021 | -3,885.00 |
| Sep 30, 2021 | 9,719.00 |
| Jun 30, 2021 | 29,839.00 |
| Mar 31, 2021 | 31,693.00 |
| Dec 31, 2020 | 13,678.00 |